Basti

Place in the classical texts

Ayurveda is a South Asian medical tradition whose classical compilations include the Charaka Samhita and the Sushruta Samhita. A review of its history describes panchakarma as a set of five cleansing actions and lists basti, the enema, as one of them, with enemas prepared from medicated oils or from herbal decoctions. The review does not give dates for the two compilations, and the other sources used for this page do not date them either.

Clinical papers from Indian Ayurvedic colleges cite the classical texts for basti. One describes basti as the major treatment directed at vata dosha, often called ardha chikitsa (half of treatment) or sarva chikitsa (complete treatment), and references both the Charaka Samhita and the Sushruta Samhita for that statement. Another, a knee osteoarthritis study, states that Charaka advises oil-based basti in vata disorders. These are the authors' references to the texts, not independent historical analysis.

Relation to Ayurveda and panchakarma

Within the tradition, basti is one procedure inside a larger panchakarma course that the history review describes in three phases: a preparatory phase, the main therapy and a follow-up regimen aimed at restoring digestion and absorption. Machipedia's Ayurveda page covers the wider tradition and its concepts, and its Panchakarma page covers the course as a whole; this page does not repeat them. The sources reviewed give no dated account of when basti first entered Ayurvedic practice.

Anuvasana and niruha types

A 2026 review describes two principal forms of basti. Anuvasana basti is oil-based, while niruha basti is decoction-based. The same paper also uses the term basti therapy for the procedure as a whole and treats it as one of the panchakarma purification procedures. One trial in rheumatoid arthritis uses the paired terms asthapana basti and anuvasana basti for its two kinds of enema, which indicates that asthapana is used in the literature for the decoction type.

Named variants in the literature

Papers name further variants, usually by the intended effect or schedule. Examples include matra basti (a small oil-based form named in a case report of a child with Hirschsprung disease), yapana basti (described by one trial as a mild type of niruha), kaala basti (a scheduled course used in the rheumatoid arthritis trial), piccha basti (cited from the Charaka Samhita in an ulcerative colitis report) and lekhana basti (used in a randomized obesity pilot). These terms are reported here only as names found in the sources.

Distinction from Western colon cleansing

Basti is framed by Ayurvedic authors as a treatment for named conditions or constitutional imbalance, not as a general bowel cleanse. Colon cleansing for general health promotion, which Machipedia covers on its Colonic Hydrotherapy page and which also appears in Naturopathy, has been reviewed as a separate subject. The abstract of that review addresses colonic cleansing for general health and does not single out basti, so its findings should not be treated as findings about basti.

How the tradition frames it

Ayurvedic authors describe basti as the most important purification procedure in panchakarma, used for specific disease conditions as well as for rejuvenation. In the tradition's terms, vata dosha is the functional principle that basti is said to act on most directly, and a 2026 review states that vata disorders are the context in which basti is given special mention. This page reports the framing as practitioners present it; the sources do not test the dosha concepts themselves.

Papers describe basti as given in courses over days to weeks, often after preparatory steps and followed by dietary guidance, and under the supervision of an Ayurvedic physician in a hospital outpatient or inpatient department. Preparations, quantities and technique are not reproduced here, and nothing on this page is a set of instructions.

Training and practice settings

The studies cited on this page come from departments of panchakarma, kayachikitsa and related departments at Ayurvedic colleges and hospitals in India, which is where the published clinical literature on basti is concentrated. The affiliations show where the research is done but do not describe the qualifications required to practice.

The World Health Organization published updated benchmarks for the training of Ayurveda in 2022, replacing a 2010 version. The page describes them as minimum criteria for establishing Ayurveda training in WHO Member States, covering competencies for practitioners and associate providers and safety in clinical use. The page does not mention panchakarma or basti, so what training in basti involves is not stated by it. In the United States, the National Center for Complementary and Integrative Health states that there is no significant regulation of Ayurvedic practice or education and that no state requires a practitioner to hold a license; its page was last updated in January 2019.

Conditions named in Ayurvedic papers

Ayurvedic authors report using basti for conditions they match to modern diagnoses, including rheumatoid arthritis (amavata), ulcerative colitis, lumbar spondylosis with low back pain (kati graha), knee osteoarthritis (sandhigata vata), chronic constipation in Hirschsprung disease (pakvasayagata vata) and obesity (sthaulya). The correspondence between Ayurvedic and biomedical disease names is the authors' own interpretation and is not established by these sources.

Rejuvenation and proposed neurological use

Ayurvedic authors describe basti as used both for specific disease conditions and for rejuvenation, a general purpose that the tradition frames in its own terms and that the sources do not test. A 2026 review in the same literature proposes basti as a candidate approach in Parkinson's disease, describing that disease as a vata-dominant condition in Ayurvedic terms. The paper presents this as a hypothesis for future testing and not as a finding.

Searches run and what they found

PubMed and Europe PMC searches combined basti, vasti, Ayurvedic enema and panchakarma with the named conditions and with review and meta-analysis. They returned case reports, single-arm studies, trial protocols, one small randomized pilot study and one hypothesis review. No systematic review dedicated to basti was found among the results screened, and the search was not exhaustive.

Small uncontrolled studies in rheumatoid arthritis, ulcerative colitis and back pain

One study of 12 patients with rheumatoid arthritis compared symptoms before and after a 21-day course of basti and reported that half showed major improvement and half minor improvement, with none in complete remission. A second report of 43 people with colonoscopy-confirmed ulcerative colitis gave basti together with several oral Ayurvedic medicines for one month and reported reductions of more than 75 percent in symptoms and in daily steroid and other anti-inflammatory drug doses.

An open-label trial of 23 people with lumbar spondylosis given a mild type of niruha basti for 15 days reported improvements in pain, range of movement and Oswestry Disability Index scores. A single-group knee osteoarthritis study recruited 30 people, of whom 25 completed a course of oil-based basti, and compared scores before and after treatment with a short follow-up. None of these four studies had a comparison group, and the colitis report combined basti with other treatments.

Parkinson's disease, constipation and obesity

For Parkinson's disease, the 2026 review proposes that basti may mimic the anti-inflammatory effect of vagus nerve stimulation through gut-brain pathways. It concludes that the hypothesis needs experimental and clinical testing and reports no patient outcomes. For constipation, the sources include one case report of a child with Hirschsprung disease treated over 14 months with several procedures and oral drugs, from which no conclusion about effect can be drawn.

A single-center, open-label, randomized pilot study assigned 64 adults with obesity to four groups, one of which received lekhana basti, and 50 completed it. The authors reported reductions in body measures and lipids in the basti groups and listed the small sample among its limitations. It is the most controlled basti study reviewed and concerns obesity only.

Limits and risk of bias

The studies share limits: small samples, no blinding, mostly no comparison group, within-group statistical tests, short follow-up and authors based in the departments that provide the treatment. Under these conditions, improvement may reflect natural variation, other treatments given alongside basti, diet and lifestyle advice, or expectation, and the sources do not allow those to be separated.

A 2009 systematic review in the American Journal of Gastroenterology found no methodologically rigorous controlled trials of colonic cleansing to support its use for general health promotion, and found multiple case reports and case series describing adverse effects. It concerned general-health colon cleansing, not basti for named conditions, so it is not carried over to basti.

Adverse events reported in basti studies

In the randomized obesity pilot, four participants stopped before completing the study because of adverse events: constipation in one, giddiness after basti in one and hyperacidity in two. The paper's conclusion also describes the treatment as free of adverse events, which does not match its own count, so the safety statement in that paper is internally inconsistent. The knee osteoarthritis study states that no adverse events were noted, and the ulcerative colitis report states that no patient developed a new complication; neither used a systematic safety method, and both were small.

No dedicated safety review or pharmacovigilance summary of basti was found among the sources reviewed. The absence of reports in small studies does not establish that harms are rare, and the sources do not give a frequency for any harm of basti.

Harms documented for enemas generally

Case reports of enemas in other settings show that serious harm is possible. A 2023 report describes an elderly woman with Parkinson's disease who had an upper rectal perforation after a hydrostatic enema and needed surgery; its abstract calls rectal perforation rare but serious and potentially fatal if not recognized promptly. A 2026 report describes a fatal case of severe hyperphosphatemia and other electrolyte disturbances after a single phosphate-containing enema in a 75-year-old woman with colonic pseudo-obstruction.

These reports involve a self-administered water enema and a commercial phosphate enema, not Ayurvedic preparations, and they show only that rectal injury and electrolyte disturbance have been documented with enemas as a class. The sources reviewed do not report infection, dehydration or contaminated basti preparations. The National Center for Complementary and Integrative Health notes that some Ayurvedic preparations may contain lead, mercury or arsenic at toxic levels; its page does not discuss enemas, so this is a general concern about product quality and not a finding about basti.

Cautions and care boundaries

The obesity pilot excluded pregnant and lactating women and people with ano-rectal conditions such as bleeding piles, fistula or fissure, along with people with several other medical conditions, and the ulcerative colitis report excluded people with complications such as anal fistula or earlier surgery. Trial exclusion criteria are not clinical contraindication lists, and the sources reviewed do not state contraindications for basti in pregnancy, haemorrhoidal bleeding, frailty or active inflammatory bowel disease. Whether basti is appropriate in those situations is therefore not settled by these sources.

Conditions such as rheumatoid arthritis, ulcerative colitis and Parkinson's disease have established medical care, and the studies above do not show that basti can replace it. Decisions about changing prescribed medicines, including steroids, belong to the treating clinician, and basti should not delay assessment of bleeding, severe abdominal pain or other new symptoms.